Amgen Oncology
@AmgenOncology
Advancing All Angles of Care. Tweets intended for U.S. audience. See our Community Guidelines: https://t.co/WUbqtYa6KT.
ID:1012121021711728640
http://amgenoncology.com 27-06-2018 23:50:30
2,7K Tweets
61,3K Followers
216 Following
Follow People
Over the weekend patients, survivors and caregivers from across the country convened in Atlanta for LUNGevity Foundation’s annual #HOPESummit , a unique event dedicated to living well with lung cancer. Amgen 🧪🔬🧬 was honored to be part of #ThisIsHope24 .
🔗Learn more: amgen.ly/3Ww7bnn
Fact: Black Americans with #lungcancer experience poorer outcomes than their white counterparts.
HEAL Collaborative works to eliminate healthcare disparities by communicating accurate info to empower people to get the care they deserve: amgen.ly/3Jg9G5B #MinorityHealthMonth
Knowing your cancer’s specific #biomarkers helps you and your healthcare team identify treatment options – now and in the future.
Learn about the role of biomarkers in gastric cancer treatment planning 🔗 amgen.ly/4cJtImn #AmgenSponsored
1 in 23 men and 1 in 25 women will be diagnosed with colorectal cancer ( #CRC ) in their lifetime. We are proud to support Fight Colorectal Cancer and their efforts to #PrioritizeCRC throughout #ColorectalCancerAwarenessMonth and beyond. #AmgenSponsored
“Without the biomarker testing, the targeted treatment wouldn’t have been a possibility.”
Gina shares her experience living with metastatic colorectal cancer in this #AmgenSponsored CURE Today article: amgen.ly/48XuiK6
#ColorectalCancerAwarenessMonth
Throughout #MyelomaACTIONMonth , we are working alongside International Myeloma Foundation to raise awareness for the disease through education, empowerment, and support for the myeloma community. #AmgenSponsored
Biomarker-informed treatment planning is powerful in the fight against colorectal cancer ( #CRC ).
Michell Baker explains how Fight Colorectal Cancer & Amgen 🧪🔬🧬 collaborate to spread biomarker testing education.
Click ⬇️ to download an #AmgenSponsored resource for CRC patients & caregivers.
Although it’s the second-most common blood cancer, multiple myeloma is rare, which can make timely diagnosis & access to treatment challenging for many patients.
Learn more from International Myeloma Foundation during #MyelomaActionMonth : amgen.ly/48Zi1ou